Free Trial

Exponent, Inc. (NASDAQ:EXPO) VP Sells $149,174.48 in Stock

Exponent logo with Business Services background
Remove Ads

Exponent, Inc. (NASDAQ:EXPO - Get Free Report) VP Richard Reiss sold 1,736 shares of Exponent stock in a transaction on Wednesday, February 26th. The stock was sold at an average price of $85.93, for a total transaction of $149,174.48. Following the transaction, the vice president now directly owns 1,800 shares in the company, valued at approximately $154,674. This represents a 49.10 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.

Exponent Price Performance

Shares of Exponent stock traded down $1.76 during trading hours on Monday, hitting $82.90. The company's stock had a trading volume of 373,861 shares, compared to its average volume of 243,302. The company has a market capitalization of $4.21 billion, a PE ratio of 39.10 and a beta of 0.71. The stock has a 50 day moving average of $89.78 and a 200 day moving average of $98.91. Exponent, Inc. has a 12 month low of $77.21 and a 12 month high of $115.75.

Exponent (NASDAQ:EXPO - Get Free Report) last posted its earnings results on Thursday, February 6th. The business services provider reported $0.46 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.40 by $0.06. Exponent had a return on equity of 27.27% and a net margin of 19.52%. During the same quarter in the previous year, the business posted $0.41 earnings per share. Equities analysts expect that Exponent, Inc. will post 1.98 EPS for the current year.

Remove Ads

Exponent Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, March 21st. Investors of record on Friday, March 7th will be issued a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.45%. This is a positive change from Exponent's previous quarterly dividend of $0.28. The ex-dividend date is Friday, March 7th. Exponent's dividend payout ratio (DPR) is presently 56.60%.

Institutional Investors Weigh In On Exponent

Several institutional investors have recently added to or reduced their stakes in EXPO. International Assets Investment Management LLC acquired a new stake in shares of Exponent in the 3rd quarter valued at about $11,261,000. Wealth Enhancement Advisory Services LLC acquired a new stake in Exponent in the 3rd quarter valued at approximately $215,000. State of Alaska Department of Revenue raised its position in Exponent by 7.2% in the 3rd quarter. State of Alaska Department of Revenue now owns 5,866 shares of the business services provider's stock valued at $676,000 after buying an additional 395 shares during the last quarter. Stephens Inc. AR bought a new stake in Exponent in the 3rd quarter valued at approximately $259,000. Finally, Conestoga Capital Advisors LLC boosted its position in Exponent by 1.6% during the 3rd quarter. Conestoga Capital Advisors LLC now owns 2,806,517 shares of the business services provider's stock worth $323,535,000 after acquiring an additional 43,257 shares during the last quarter. 92.37% of the stock is owned by institutional investors.

Exponent Company Profile

(Get Free Report)

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.

Further Reading

Insider Buying and Selling by Quarter for Exponent (NASDAQ:EXPO)

Should You Invest $1,000 in Exponent Right Now?

Before you consider Exponent, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.

While Exponent currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

3 Stocks That Wall Street Insiders Can't Stop Buying

3 Stocks That Wall Street Insiders Can't Stop Buying

Corporate insiders are snapping up shares of these three stocks heading into the new year; why this list of companies with insider buying might surprise you.

Recent Videos

Is There Still Money in AI? How to Invest in the Next Big Wave
AMD at Rock Bottom? Analysts Predict a MAJOR Rebound!
Massive Buybacks: 3 Stocks Insiders Are Buying Up

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads